As of 2025-07-05, the Relative Valuation of Helix Biopharma Corp (HBP.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.97 CAD, the upside of Helix Biopharma Corp based on Relative Valuation is -101.4%.
The range of the Relative Valuation is (0.01) - (0.04) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.3x | 0.1x |
| Forward P/E multiples | -1.4x - 0.3x | 0.1x |
| Fair Price | (0.01) - (0.04) | (0.01) |
| Upside | -101.1% - -104.1% | -101.4% |
| Date | P/E |
| 2025-07-03 | -7.23 |
| 2025-07-02 | -7.23 |
| 2025-06-30 | -6.94 |
| 2025-06-27 | -7.09 |
| 2025-06-25 | -6.94 |
| 2025-06-24 | -6.94 |
| 2025-06-23 | -6.94 |
| 2025-06-20 | -6.71 |
| 2025-06-19 | -6.71 |
| 2025-06-18 | -6.86 |
| 2025-06-17 | -6.79 |
| 2025-06-16 | -6.79 |
| 2025-06-09 | -6.94 |
| 2025-05-28 | -6.86 |
| 2025-05-27 | -6.86 |
| 2025-05-26 | -7.09 |
| 2025-05-22 | -7.16 |
| 2025-05-20 | -7.09 |
| 2025-05-16 | -7.16 |
| 2025-05-15 | -7.23 |
| 2025-05-14 | -7.16 |
| 2025-05-13 | -7.16 |
| 2025-05-12 | -7.16 |
| 2025-05-09 | -7.16 |
| 2025-05-08 | -7.09 |
| 2025-05-06 | -7.16 |
| 2025-05-01 | -7.16 |
| 2025-04-30 | -7.16 |
| 2025-04-29 | -5.82 |
| 2025-04-28 | -5.82 |
| 2025-04-25 | -5.82 |
| 2025-04-24 | -5.82 |
| 2025-04-23 | -5.82 |
| 2025-04-22 | -5.74 |
| 2025-04-15 | -5.82 |
| 2025-04-14 | -5.82 |
| 2025-04-11 | -5.74 |